# VA NEPHRON-D: Diabetes iN Nephropathy Study

> **NCT00555217** · PHASE3 · TERMINATED · sponsor: **US Department of Veterans Affairs** · enrollment: 1448 (actual)

## Conditions studied

- Kidney Disease
- Nephropathy
- Type 2 Diabetes

## Interventions

- **DRUG:** losartan
- **DRUG:** lisinopril

## Key facts

- **NCT ID:** NCT00555217
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 1448 (ACTUAL)
- **Why stopped:** It was stopped primarily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555217, "VA NEPHRON-D: Diabetes iN Nephropathy Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00555217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*